CeloNova BioSciences, Inc. specializes in advanced polymer surface coating technologies aimed at enhancing the safety and performance of medical devices. Their flagship product, Polyzene-F (PzF) nanocoating, is characterized by its ultra-purity, elasticity, and high molecular weight, which contribute to its exceptional biocompatibility. This innovative coating is designed to minimize thrombosis and inflammation, making it suitable for a variety of vascular implants, including coronary stents and neurovascular devices. The company also offers the Xero-Gel Drug-Coated PTCA Balloon, which features a bioactive coating that optimizes drug delivery for treating conditions like small vessel stenosis and restenosis.

In addition to their proprietary coatings, CeloNova has a history of successful applications in cardiology and oncology, with products like the COBRA PzF NanoCoated Coronary Stent and Embozene™ Microspheres. These products are engineered to be "invisible" to the body, significantly reducing inflammatory responses and improving patient outcomes. CeloNova's commitment to innovation and partnership opportunities positions them as a leader in the medical technology industry, focusing on solving complex clinical challenges related to device-induced complications.

United States

CeloNova BioSciences is now ALTA Biomaterials!
In Jan 2023, CeloNova BioSciences has become Alta Biomaterials! Alta Biomaterials is an expert design and development partner to medical device OEMs looking for proprietary coating and surface modification technologies that enhance biocompatibility and drug delivery while providing anti-inflammatory, thromboresistance and pro-healing properties.

CeloNova BioSciences, Inc.

Company Details